Introduction Transanal total mesorectal excision (TaTME) has rapidly emerged as a novel approach for rectal cancer surgery. Safety profiles are still emerging and more comparative data is urgently needed. This study aimed to compare indications and short-term outcomes of TaTME, open, laparoscopic, and robotic TME internationally.
Introduction
The best technique to achieve safe and effective total mesorectal excision (TME) for rectal cancer continues to pose a significant challenge for surgeons and patients. The ideal technique aims for an intact TME with clear circumferential and distal resection margins [1] . When reconstruction is planned, an anastomotic technique that minimises the risk of leak whilst promoting good function is needed. A significant challenge is posed by cancers in the lowest third of the rectum, particularly in a narrow pelvis. From an abdominal approach, the ability to pass a stapler safely below the tumour is vital to avoid an involved distal resection margin. Similarly, the need for multiple firings of a cross-stapler predisposes to anastomotic leak [2] . Finally, precise placement of circular stapling devices through cross-stapled rectal stumps can be challenging.
Transanal TME (TaTME) has been proposed as a method to improve surgery of mid and low rectal lesions [3, 4] . It is typically performed as a hybrid procedure with a minimally invasive (laparoscopic or robotic) abdominal approach, with dissection and ultralow colorectal/coloanal anastomosis through the transanal port to improve visualisation and avoid cross stapling [5] or multiple firings [2, 5] . It has the potential to be safer for the distal resection margin by improving access and precision of dissection and stapler placement [2] . TaTME is still evolving (IDEAL Phase 2b) with moderate stability of its components [6, 7] . A prolonged learning curve [8] for transanal surgery has been described, with worse outcomes seen in as many as the first fifty cases performed [9] . Consistent with this, early series report anastomotic leak rates as high as 43% [10] , with concerning rates of urethral and other solid organ injury. Concerns also exist about circumferential resection margin (CRM) involvement and suboptimal TME specimen grades in its early adoption [9, 11] . There is not yet randomised evidence for the benefit of TaTME. A recent large and comprehensive registry study has identified baseline data and showed acceptable leak rates and safety profiles from the included centres [12] . However, it did not have comparative groups to benchmark current practice, and so to supplement this, we planned a study from a wide range of centres to gather comparative data. The primary aim of this study was to describe the safety profile of TaTME compared to other surgical approaches to manage rectal cancer. The secondary aim was to additionally describe the current landscape in terms of uptake of TaTME and the alternate operative approaches for rectal cancer, including open, laparoscopic, and robotic TME.
Method Protocol and centres
This prospective, observational, multicentre study was conducted in line with a pre-specified protocol (http://www.escp.eu.com/research/cohort-studies). An external pilot of the protocol and data capture system was conducted in five international centres prior to launch, allowing refinement of the study tool and delivery. Any unit performing gastrointestinal surgery was eligible to register to enter patients into the study. No minimum case volume, or centre-specific limitations were applied. The study protocol was disseminated to registered members European Society of Coloproctology (ESCP), and through national surgical or colorectal societies, and represents a pre-planned analysis of the European Society of Coloproctology 2017 audit database.
Study approvals
All participating centres were responsible for compliance to local approval requirements for ethics approval or indemnity as required. In the UK, the National Research Ethics Service tool recommended that this project was not classified as research, and the protocol was registered as clinical audit in all participating centres.
Patient eligibility
Adult patients (> 16 years) undergoing elective (planned) rectal resection with or without a primary anastomosis were extracted from the main audit database. Only operations performed for a malignant pathology within the rectum, up to the rectosigmoid junction were included. For the abdominal component, open, laparoscopic and robotic procedures were all eligible. Transanal and non-transanal approaches were acceptable. Rectal resections performed as part of a more extensive resection (e.g. panproctocolectomy) were excluded.
Data capture
Consecutive sampling was performed of eligible patients over an 8-week study period in each included centres. Local investigators commenced data collection on any date between the 1 January 2017 and 15 March 2017, with the last eligible patient being enrolled on 10 May 2017. This study adopted the UK National Research Collaborative model for data collection and follow-up. Small teams of up to five surgeons or surgical trainees worked together to collect prospective data on all eligible patients at each centre. Quality assurance was provided by at least one consultant or attending-level surgeon. Data was recorded contemporaneously and stored on a secure, user-encrypted online platform (REDCap) without using patient identifiable information. Centres were asked to validate that all eligible patients during the study period had been entered, and to attain > 95% completeness of data field entry prior to final submission.
Outcome measure
The primary outcome measure was overall anastomotic leak, pre-defined as either (i) gross anastomotic leakage proven radiologically or clinically, or (ii) the presence of an intraperitoneal (abdominal or pelvic) fluid collection on post-operative imaging. The secondary outcome measures were the postoperative major complication rate; defined as Clavien-Dindo classification grade 3-5 (reoperation, reintervention, unplanned admission to critical care, organ support requirement or death), postoperative length of stay (in whole days); with day of surgery as day zero, the intraoperative serious adverse event (SAE) rate, and the circumferential resection margin involvement rate; defined as tumour tissue ≤ 1 mm from the resection margin.
Statistical analysis
This report has been prepared in accordance to guidelines set by the STROBE (strengthening the reporting of observational studies in epidemiology) statement for observational studies [13] . Patient, disease and operative characteristics were compared by type of surgical approach (open, laparoscopic -transanal (TaTME), laparoscopic -not transanal, robotic -transanal (TaTME), robotic -not transanal) and by the presence or absence of the primary outcome measure (anastomotic leak or intraperitoneal collection) using Student's t-test for normal, continuous data, Mann-Whitney U test for non-normal continuous data or Chi-squared test for categorical data. To test the association between overall anastomotic leak and approach (the main explanatory variable) two models were fitted: the first was a mixed-effects logistic regression model using the whole dataset, the second was a propensity scorematched group of patients who did and did not undergo TaTME in a 1:2 ratio. In the mixed-effects model, clinically plausible patient, disease and operation-specific factors were entered into the model for risk-adjustment, treated as fixed effects. These were defined a priori within the study protocol, and included irrespective of their significance on univariate analysis. Hospital was entered into the model as a random-effect, to adjust for hospital-level variation in outcome. Propensity score matching was used to estimate the effect of approach (transanal versus not transanal perineal approach) by accounting for confounding co-variables that might predict patient selection. Nearest neighbour matching was used with scores calculated from variables selected a priori for model adjustment (age, gender, anastomotic height, AJCC stage), and outputs were examined using jitter plots and Chisquared testing to observe any significant differences between groups. A second propensity-score matched multivariable logistic regression model was then fitted to explore the association of operative approach and anastomotic leak. Effect estimates are presented as odds ratios (OR) with 95% confidence intervals (95% CI) and two-tailed P-values. An alpha level of 0.05 was used throughout. Model discrimination was tested by calculating a C-statistic (analogous to the area under the Receiver Operating Curve (AUC); 0.5: no discrimination; 0.6, adequate; 0.7, good; 0.8 excellent). Multiple imputation was not required as the data completeness rate was very high for data points used for propensity score matching. Data analysis was undertaken using R Studio V3.1.1 (R Foundation, Boston, MA, USA). 
Results

Patient demographics
Patient, disease and operative characteristics by operative approach
There was variation in the selection of patients for different approaches to rectal cancer surgery (Table 1) . Of patients undergoing restorative surgery, 15.9% (312/1966) of patients from 189 centres underwent surgery with a transanal perineal approach and minimally invasive abdominal approach (TaTME), ranging from one to 15 submitted cases per centre. 6.4% (126/1966) of patients from 40 centres had robotic surgery (ranging from one to 18 submitted case per centre). In patients undergoing TaTME, the anastomosis was was stapled in 73.7% (230/312) and handsewn in 26.3% (82/312). The proportion of males undergoing transanal and robotic approaches was slightly higher when compared to the other procedures (68.4%, 68.3%, 64.4% vs 61.8%, 60.6% respectively; P = 0.06). Transanal or robotic approaches were significantly more likely to be selected in low risk ASA 1-2 patients and earlier stage disease.
Anastomotic leak
Within the patients undergoing restorative anastomosis, the overall leak rate was 9.0% (175/1951, with 15 missing outcome data (< 1%)). In the unadjusted data, the anastomotic leak rate was higher in TaTME (12.9%, 45/311, one missing outcome data (< 1%)) than nontransanal TME (8.9%, 135/1520; Fig. 3 ). The highest leak rate was seen in robotic surgery, and more major complications were seen in transanal and robotic surgery ( Table 2 ). In the univariate analysis both laparoscopic TaTME (OR 1.61, 1.02-2.48, P = 0.04) and robotic TaTME (OR 3.05, 1.10-7.34, P = 0.02) were associated with a higher risk of anastomotic leak than nontransanal laparoscopic TME. Once adjusted for confounders (Table 3 , Fig. 4 ), transanal surgery was no longer significantly associated with leak (OR 1.23, 0.77-1.97, P = 0.39 and OR 2.11, 0.79-5.62, P = 0.14 respectively), whilst low rectal anastomosis (OR 2.72, 1.55-4.77, P < 0.001) and male gender (OR 2.29, 1.52-3.44, P < 0.001) were strongly associated. The model demonstrated fair discrimination (AUC: 0.70). Propensity score matching gave balanced groups (Table 4 ). In the propensity matched multivariable model (Table 5) , transanal approach was not associated with overall anastomotic leak (OR 1.14, 0.70-1.81, P = 0.595). However, male gender (OR 2.88, 1.64-5.38, P < 0.001) and low rectal anastomosis (OR 3.92, 1.74-10.52, P = 0.002) again remained strong predictors for anastomotic leak.
Circumferential resection margin
In the unadjusted data, restorative surgery had a lower CRM positivity rate (36/1733, with 232 missing outcome data (11.8%)) than non-restorative (58/ 549) operations (2.3% versus 10.6%). Overall, there was a low CRM positive rates across all approach types to rectal resection with restorative anastomosis (0-4.7%, Table 2 ). For the low rectum, robotic surgery had a lower positive margin rate than laparoscopic surgery (0/19 with a transanal perineal approach, and 1/27 with a non-transanal approach; Table 6 ). However, in a mixed-effects model (Table 7) , none of the operative approaches were significantly associated with margin positivity except for non-restorative surgery. The model demonstrated fair discrimination (AUC: 0.72).
Discussion
This study supports the use of a TaTME approach for rectal cancer resection, with comparable postoperative outcomes and pathological safety compared to other approaches. This is in line with recent evidence on TaTME delivery across Europe [12, 14, 15] . The leak rate was higher than previously reported, at 12.9%, which at univariable level was significantly higher than other techniques. Once adjusted for confounders, this variability was largely a result of anastomosis in the lowest part of the rectum; transanal surgery became nonsignificant in mixed-effects and propensity-score matched models. By including other techniques within this study, it allows individual surgeons and units to benchmark practice and consider their own selection of patients. TaTME was more commonly used in men, in those undergoing long course chemoradiotherapy and in those with low tumours. This parallels current recommendations for the selection of patients, demonstrating appropriate adoption of this technique within included centres [5, 16] . Leak rates after transanal (TaTME) surgery have been reported as 4.7% to 9.1% in recent systematic reviews [5, 11] and 6.7% in a subsequent large international registry [17] . We add to this literature by providing an unselected, 'real-world' view of implementation of TaTME internationally in a prospective setting, with risk-adjustment of outcome data with mixed-effects modelling. The higher unadjusted leak rate identified in the present study may reflect learning curve effects from centres being at variable stages of adoption of the technique. It may also reflect the fact that we only included malignant conditions. An important variability between studies still exists in how anastomotic leakage is defined and detected. By comparing leakage to a simultaneous cohort of laparoscopic, open and robotic resections from the same centres, we can explore and control for case selection variability by approach and mitigate against concerns of reporting bias. Reassuringly, male gender and low tumour height were strongly predictive factors for leak in our mixed effects models, which is consistent with current knowledge [18] [19] [20] . Whilst our data gives evidence for safety in the current dissemination of TaTME, structured training with proctorship from experienced proponents remains essential.
Improved pathological and oncological outcomes are a potential benefit of TaTME. The positive resection margin rate in restorative surgery from this study (4.0%) is consistent with previous reports, including the transanal component [5] . Fleshman et al. [21] previously reported a significantly lower difference rate of CRM involvement with TaTME when compared with laparoscopic TME. In contrast, the Bordeaux randomized trial found a significantly greater rate of CRM involvement for laparoscopic TME when compared to TaTME (18.0% vs 4.0%, P = 0.025) although this did not mean a decrease in local recurrence (long term oncological outcomes) [22] . The low positive CRM rates seen with robotic surgery in the lower rectum within the present study are likely to represent a degree of case selection at a site level; results from randomised trials in TaTME and robotic rectal cancer surgery are awaited.
This study also provides valuable information for other resection techniques. Recent randomised trials have suggested laparoscopic TME may lack oncological safety compared to open surgery in the mid and low rectum (ALaCaRT and ACOSOG) [21, 22] . The present study shows pathological equivalence of laparoscopic and open approaches, with a selection variability evident that suggests surgeons are carefully and correctly selecting patients for each approach; this is consistent with COLOR II, COREAN and CLASiCC trials [18, 19, 23] . There were relatively few robotic cases in this cohort. Where robotics was performed, the positive CRM and conversion rates were lower when compared to laparoscopic techniques. The ROLARR trial with 471 patients did not show differences between laparoscopic and robotic for positive resection margin [24] . International registry studies alongside ROLARR reported a rate of conversion from laparoscopic to open or transanal of 6.3%. We found significant differences between laparoscopic transanal that presented the highest rate of conversion (16.2%) and robotic transanal (0%). This is consistent with the findings of ROLARR trial about the potential for robotic surgery to decrease the rate of conversion. Finally the APER rate provides a contemporary permanent stoma rate across a variety of international sites for an operation with known variability between units [25] . Our group plans to produce a future report describing geographic variability in colorectal surgery, exploring differences in patient factors, disease presentations and techniques utilised internationally, across the last three international ESCP audits.
This study has limitations. Unadjusted outcomes showed higher major complication rates with robotic surgery and also transanal surgery, although without risk adjustment for confounding factors this must be interpreted with significant caution. Further research is needed to correctly risk-adjust for individual surgeon, or surgical team experience in TaTME, as well as unmeasured patient, tumour and operation-specific factors. Similarly, standardised definitions of anastomotic leakage and its detection remain uncommonly used between studies. Selection bias is an unavoidable factor in this type of observational research. We have attempted to minimize the effects of this by undertaking adjusted analyses using mixed-effects logistic regression models, but accept that this can never fully counteract the nuances involved in clinical decisionmaking. This said, the current study was designed to detect safety differences in current practice rather than test efficacy of treatments directly.
Results from randomised trials comparing outcomes after the variety of approaches available for rectal cancer surgery are now needed, particularly evaluating TaTME against laparoscopic TME without a transanal perineal component [26] . Overall anastomotic leak was pre-defined as either (i) gross anastomotic leakage proven radiologically or clinically, or (ii) the presence of an intraperitoneal (abdominal or pelvic) fluid collection on post-operative imaging. Odds ratio (OR) presented with 95% confidence intervals. 
